A A A

Current review panels

Review panels are composed for specific competitions and membership will depend on the expertise needed. Please select the appropriate competition for current information on panel composition.

Note:

For competitions with an LOI stage - panels may be reduced between stages depending on expertise required to review the full application. Panel members participating in the LOI review only will be marked with an *.

For competitions with multiple panels – applicants indicate their panel recommendation, however, final panel selection will be determined by the panel chairs and CCSRI based on the panel with the most appropriate expertise.

Innovation Grant and Innovation to Impact Grant panels

I1a - Biomarkers and Genomics

Including genomics, proteomics, metabolomics (and other ‘omics’), high-throughput sequencing, bioinformatics, diagnostic, prognostic and predictive biomarkers, circulating tumour cells.

Panel meeting: December 11, 2014

Wan Lam, PhD (Chair) BC Cancer Agency
Vancouver, BC
Bharati Bapat, PhD 

Mount Sinai Hospital
Toronto, ON 

Guilaumme Bourque, PhD  McGill University
Montreal, QC 
Robert Day, PhD  University of Sherbrooke
Sherbrooke, QC
Harriet Feilotter, PhD  Queen's University
Kingston, ON
Cheryl Helgason, PhD  BC Cancer Research Centre
Vancouver, BC 
Maja Krajinovic, MD/PhD  CHU Sainte-Justine Research Centre
Montreal, QC
Julian Lum, PhD  BC Cancer Agency
Vancouver, BC
Paola Marigani, MBA/PhD  Dalhousie University
Halifax, NS 
Raymond Ng, PhD  University of British Columbia
Vancouver, BC 
Sohrab Shah, PhD  BC Cancer Agency
Vancouver, BC 
Pierre Thibault, PhD  IRIC
Montreal, QC 
Raymond Ng, PhD  University of British Columbia
Vancouver, BC 
Graham Dellaire, PhD
(Scientific Officer)
Dalhousie University
Halifax, NS
William Lockwood, PhD (Scientific Officer) BC Cancer Agency
Vancouver, BC

 

I1b - Gene Regulation & Cellular Biology

Including mechanisms of transcriptional control, epigenetics, chromatin structure and function, translational control, RNA biology, post-translational modifications, telomere function, DNA damage and repair, organellar biology, model organisms, angiogenesis, cell migration, cell invasion, tumour environment.

Panel meeting: December 9-10, 2014

John White, PhD (Chair) McGill University
Montreal, QC
Shariaz Baksh, PhD  University of Alberta
Edmonton, AB 
John Bergeron, PhD  McGill University
Montreal, QC 
Rod Bremner, PhD  Mount Sinai Hospital
Toronto, ON 
Sean Egan, PhD  Hospital for Sick Children
Toronto, ON 
Gerardo Feybeyre, PhD  University of Montreal
Montreal, QC 
Imed Gallouzi, PhD  McGill University
Montreal QC 
Murray Junop, PhD  McMaster University
Hamilton, ON 
Mathieu Lupien, PhD  Ontario Cancer Institute/PMCC
Toronto, ON 
Arnim Pause, PhD  McGill University
Montreal, QC 
Uri Tabori, PhD  Hospital for Sick Children
Toronto, ON 
Isabella Tai, MD/PhD  University of British Columbia
Vancouver, BC 
Theodoros Tsakiridis, MD/PhD  Jurvanski Cancer Centre
Hamilton, ON 
Judy Wong, PhD  University of British Columbia
Vancouver, BC 
Christopher Nelson, PhD 
(Scientific Officer)
University of Victoria
Victoria, BC
Leonardo Salmena, PhD (Scientific Officer) University of Toronto
Toronto, ON 

 

I2 - Imaging and Technology Development

Including platform and tool development, systems biology, magnetic resonance imaging (MRI), positron emission tomography (PET), ultrasound, computer tomography (CT), radiobiology, radiotherapy, photodynamic therapy (PDT), optical imaging, microfluidics, nanotechnology.

Panel meeting: December 3, 2014

Michael Patterson, PhD (Chair) McMaster University
Hamilton, ON
Daniel Côté, PhD  Laval University
Quebec City, QC 
 Paula Foster, PhD  Western University
London, ON
Todd Hoare, PhD  McMaster University
Hamilton, ON 
Marianne Koritzinsky, PhD  Ontario Cancer Institute/PMCC
Toronto, ON
Boyd McCurdy, PhD 

Cancer Care Manitoba
Winnipeg, MB 

Cynthia Ménard  Ontario Cancer Institute/PMCC
Toronto, ON 
Andrew Minchinton, PhD  BC Cancer Agency
Vancouver, BC 
Mark Niedre, PhD  Northeastern University
Boston, MA
Brian Nieman, PhD  Hospital for Sick Children
Toronto, ON 
Christopher Phenix, PhD  Thunder Bay Regional Research Institute
Thunder Bay, ON 
Jacek Tuszynski, PhD  University of Alberta
Edmonton, AB 
Roger Zemp, PhD  University of Alberta
Edmonton, AB 
Aaron Ward, PhD 
(Scientific Officer)
London Health Sciences Centre
London, ON
Hai-Ling (Margaret) Cheng, PhD (Scientific Officer)  Hospital for Sick Children
Toronto, ON 

 

I3 - Immunology, Signalling and Stem Cells

Including metastasis, hormone-sensitive pathways, growth-factor mediated signalling, immunotherapies, viral therapeutics, cancer stem cells, signal transduction, innate immunity and infection, tumour antigens, immune surveillance, hematopoiesis.

Panel meeting: December 8-9, 2014

Jayne Danska, PhD (Chair) Hospital for Sick Children
Toronto, ON
Jean-Francois Cotê, PhD University of Montreal
Montreal, QC
Shoukat Dedhar, PhD  BC Cancer Agency
Vancouver, BC 
Spencer Gibson, PhD  University of Manitoba
Winnipeg, MB 
Stephen Girardin, PhD  University of Toronto
Toronto, ON 
John Hiscott, PhD VGHI Florida
Port Saint Lucie, FL
Norman Iscove, MD/PhD  Ontario Cancer Institute/PMCC
Toronto, ON 
Kevin Kane, PhD  University of Alberta
Edmonton, AB
Rayjean Lapointe, PhD  CHUM
Montreal, QC 
Mani Larijani, PhD  Memorial University of Newfoundland
St. John's, NL
Mark Minden, MD/PhD  Ontario Cancer Institute/PMCC
Toronto, ON 
Catherine O'Brien, MD/PhD  Ontario Cancer Institute/PMCC
Toronto, ON 
Afshin Raouf, PhD  University of Manitoba
Winnipeg, MB
Sheila Singh, PhD  McMaster University
Hamilton, ON
Josie Ursini-Siegel, PhD  McGill University
Montreal, QC
David Stojdl, PhD  Children’s Hospital of Eastern Ontario
Ottawa, ON 
Jean-Simon Diallo, PhD (Scientific Officer) Ottawa Hospital Research Institute
Ottawa, ON 
Simon Turcotte, MD 
(Scientific Officer)
CHUM
Montreal, QC

 

I4 - Novel Therapeutics

Including drug candidates, rational drug design, hit and target validation, compound screening, medicinal chemistry, pharmacology, drug delivery systems, drug transport, drug resistance, combination therapies and pharmacogenomics.

Panel meeting: December 1-2, 2014

Michel Roberge, PhD (Chair) University of British Columbia
Vancouver, BC
Gervais Bérubé, PhD  University of Quebec at Trois-Rivieres
Trois-Rivieres, QC 
Ann Chambers, PhD  Western University
London, ON 
Jason Crawford, PhD  The Centre for Drug Research and Development
Vancouver, BC
Daniel De Carvalho, PhD  Ontario Cancer Institute/PMCC
Toronto, ON 
Elizabeth Gillies, PhD  Western University
London, ON 
Mark Glover, PhD 

University of Alberta
Edmonton, AB 

Stephen Haggarty, PhD Harvard University
Boston, MA
Jason Moffat, PhD  University of Toronto
Toronto, ON 
Alain Nepveu, PhD  McGill University
Montreal, QC 
Corey Nislow, PhD  University of British Columbia
Vancouver, BC 
Benoit Paquette, PhD  Universite de Sherbrooke
Sherbrooke, QC 
Kevin Petrecca, MD/PhD  McGill University
Montreal, QC 
Lynne-Marie Postovit, PhD  University of Alberta
Edmonton, AB
Gregory Steinberg, PhD  McMaster University
Hamilton, ON 
David Uehling, PhD  Ontario Institute for Cancer Research
Toronto, ON 
Tommy Alain, PhD (Scientific Officer) Children's Eastern Ontario Hospital
Ottawa, ON 
Rodger Tiedemann, PhD (Scientific Officer) Ontario Cancer Institute/PMCC
Toronto, ON

 

I5 - Prevention and Cancer Outcomes 

Including epidemiology, prevention interventions, lifestyle and environmental risk factors, health economics, health services, quality of life, survivorship, palliative care, psychosocial issues, knowledge translation and exchange.

Panel meeting: December 2, 2014

Patricia Parker, PhD (Chair) University of Texas
Houston, TX, USA
Andrea Cherrington, MD  University of Alabama at Birmingham
Birmingham, AL
Ilona Csizmadi, PhD  University of Alberta
Calgary, AB 
Hugh Davies, PhD  University of British Columbia, Vancouver, BC 
Wendy Duggleby, PhD/RN  University of Alberta
Edmonton, AB 
Michelle Janelsins, MPH/PhD University of Rochester
Rochester, NY
Linda Keleman, PhD  Medical University of South Carolina
Charleston, SC 
Karen Kopciuk, PhD  Alberta Health Services
Calgary, AB 
Loraine Marrett, PhD  Cancer Care Ontario
Toronto, ON 
Sara McEwen, PhD

Sunnybrook Research Institute
Toronto, ON

Nicole Mittmann, PhD  Sunnybrook Research Institute
Toronto, ON 
Lillian Sung, MD/PhD  Hospital for Sick Children
Toronto, ON 
Thomas Tenkate, PhD  Ryerson University
Toronto, ON
Amanda Caissie, MD/PhD (Scientific Officer) Dalhousie University
Halifax, NS
Ryan Kennedy, PhD (Scientific Officer) Propel Centre for Population Health Impact
Waterloo, ON

 

 

∆ indicates Innovation Grant review only

Impact Grant panel

LOI review teleconference: June 23, 2014
Panel meeting: November 19, 2014

John Bell, PhD (Co-Chair) Ottawa Hospital Research Institute
Ottawa, ON 
Michael Brundage, MD
(Co-Chair)
Kingston General Hospital
Kingston, ON
Marcel Bally, PhD  BC Cancer Agency
Vancouver, BC
J. Gregory Cairncross, MD  University of Calgary
Calgary, AB 
Andrew Craig, PhD  Queen's University
Kingston, ON
*Aaron Fenster, PhD  Western University
Toronto, ON 
Steven Gallinger, MD  Toronto General Hospital
Toronto, ON 
Cynthia Hawkins, MD/PhD 

Hospital for Sick Children
Toronto, ON 

Rayjean Hung, PhD  Mount Sinai Hospital
Toronto, ON 
Rama Khokha, PhD  Ontario Cancer Institute/PMCC
Toronto, ON 
Nathalie Labrecque, PhD University of Montreal
Montreal, QC
David Litchfield, PhD  Western University
London, ON 
*Calum MacAulay, PhD  BC Cancer Agency (Vancouver)
Vancouver, BC 
Torsten Nielsen, MD/PhD  University of British Columbia
Vancouver, BC 
*Ivo Olivotto, MD  Tom Baker Cancer Centre
Calgary, AB 
Claude Perreault, MD  IRIC
Montreal, QC 
*Paul Pharoah, PhD  University of Cambridge
Cambridge, UK 
Peter Siegel, PhD  McGill University
Montreal, QC
*Gurmit Singh, PhD  McMaster University
Hamilton, ON 
Brad Wouters, PhD Ontario Cancer Institute/PMCC
Toronto, ON
Jeffrey Wrana, PhD Mount Sinai Hospital
Toronto, ON
Rayjean Hung, PhD (Scientific Officer)  Mount Sinai Hospital
Toronto, ON 
Shyh-Dar Li, PhD (Scientific Officer) University of British Columbia
Vancouver, BC 
Dawn Ashforth (Community Representative) Canadian Cancer Society – Ontario Division 

Prevention Research Grant panel

Panel meeting: June 27, 2014
Alexander S. Parker (Chair)  Mayo Clinic
Jacksonville, FL, USA
Bruce Baskerville University of Waterloo
Waterloo, ON
Jennifer D Brooks  Memorial Sloan-Kettering Cancer Center
New York, NY, USA 
Winson Y. Cheung BC Cancer Agency (Vancouver)
Vancouver, BC
S. Michelle Dreidger

University of Manitoba
Winnipeg, MB

Alison Duncan University of Guelph
Guelph, ON
Heather A. Eliassen

Brigham and Women's Hospital
Boston, MA, USA

Jose R. Fernandez University of Alabama-Birmingham
Birmingham, AL, USA
Vincent Fradet  Laval University
Quebec City, QC 
Walter H. Gotlieb  McGill University
Montreal, QC
Nancy Kreiger Cancer Care Ontario
Toronto, ON
Chizimuzo Okoli  University of Kentucky
Lexington, KT, USA 
Kimberly Robien  George Washington University
Washington, DC, USA 
Alberto Severini  Public Health Agency of Canada
Winnipeg, MB 
Thomas Tenkate  Ryerson University
Toronto, ON 
Enam Alsrayheen (Community Representative) Canadian Cancer Society - British Columbia/Yukon Division 
Sarah Vollett (Community Representative) Canadian Cancer Society - British Columbia/Yukon Division 

CCS-Partner Prevention Research Grant panel

LOI review teleconference: April 29, 2014
Panel meeting: September 30, 2014

Richard (Dick) Clayton, PhD (Chair)  University of Kentucky
Lexington, KY, USA
Tracie Barnett, PhD  University of Montreal
Montreal, QC 
Ulrike (Uli) Boehmer, PhD  Boston University
Boston, MA, USA 
Anne Leis, PhD

University of Saskatchewan
Saskatoon, SK

S. Elizabeth McGregor, PhD  Alberta Health Services
Calgary, AB 
Annette Schultz, PhD/RN  University of Manitoba
Winnipeg, MB 
Siobhan Sutcliffe, PhD  Washington University School of Medicine
St. Louis, MO, USA
Shelley Tworoger, PhD  Harvard University
Boston, MA, USA 
Melanie Keats, PhD (Scientific Officer) Dalhousie University
Halifax, NS 
Sylvie Poissant (End User)  Canadian Cancer Society - Quebec Division
Montreal, QC
Anne McTiernan-Gamble (End User)  Canadian Cancer Society - New Brunswick Division
Saint John, NB
Julie Stratton (End User)  Region of Peel, Public Health
Mississauga, ON

Capacity Development Awards in Prevention Research panel

Panel meeting: June 18, 2014

Christine Friedenreich (Chair)  Alberta Health Services – Cancer Care
Calgary, AB
Hal Berman  Toronto General Hospital
Toronto, ON 
Denise Daley University of British Columbia
Vancouver, BC
Geoffrey Fong University of Waterloo
Waterloo, ON 
Katherine Frohlich

University of Montreal
Montreal, QC

Lise Gauvin 

University of Montreal
Montreal, QC 

Sam Harper McGill University
Montreal, QC
Shelley Harris

CancerCare Ontario
Toronto, ON

Julia Knight Mount Sinai Hospital
Toronto, ON
Salaheddin Mahmud University of Manitoba
Winnipeg, MB
Jennifer Yessis (Scientific Officer) 

University of Waterloo
Waterloo, ON 

Quality of Life Grant panel

LOI review teleconference: September 11, 2014
Panel meeting: January 15, 2015

Jamie Studts, PhD 
(Chair)
University of Kentucky
Lexington, KY
Maru Barrera, PhD Hospital for Sick Children
Toronto, ON 
Cristina Caperchione, PhD University of British Columbia (Okanagan)
Kelowna, BC
Anees Chagpar, MD Yale University
New Haven, CT
*Catherine Classen, PhD  Women’s College Research Institute
Toronto, ON 
*Nicole Culos-Reed, PhD University of Calgary
Calgary, AB 
Kristine Donovan, PhD/MBA  Moffitt Cancer Center and Research Institute
Tampa, FL
*Bruno Gagnon, MD Laval University
Quebec City, QC
*Melissa Henry, PhD  Jewish General Hospital
Montreal, QC 
Suzanne Lechner, PhD  University of Miami
Miami, FL 
*Christopher Longo, PhD McMaster University
Hamilton, ON
*Donald Mabbott, PhD Hospital for Sick Children
Toronto, ON
Suzanne O’Neill, PhD Georgetown University
Washington, DC
Gregory Pond, PhD  McMaster University
Hamilton, ON
John Schmidt, PhD  University of Pittsburgh
Pittsburgh, PA 
Allen Sherman, PhD  University of Arkansas for Medical Sciences
Little Rock, AR
Robin Vanderpool, PhD  University of Kentucky
Lexington, KY
Erika Waters, PhD/MPH Washington University in St. Louis
St Louis, MO
*Rebecca Wong, MD  Ontario Cancer Institute/PMCC
Toronto, ON 
James Wright, MD  Juravinski Cancer Centre, Hamilton Health Sciences
Hamilton, ON
Tallal Younis, MD  Dalhousie University
Halifax, NS 
Sarah Hales, MD (Scientific Officer) Princess Margaret Cancer Centre
Toronto, ON 
Breffni Hannon, MD 
(Scientific Officer)
Princess Margaret Cancer Centre
Toronto, ON

Knowledge to Action Grant panel

Panel meeting: May 13, 2014

Jon Kerner (Chair)  Canadian Partnership Against Cancer
Toronto, ON 
H. Sharon Campbell University of Waterloo
Waterloo, ON
Deborah Dudgeon  Queens University
Kingston, ON 
Melissa Henry McGill University
Montreal, QC 
Deborah K. Mayer  University of North Carolina-Chapel Hill
Chapel Hill, NC 
Marie-Hélène Mayrand  University of Montreal
Montreal, QC 
Martine Puts  University of Toronto
Toronto, ON 
Marko Simunovic McMaster University
Hamilton, ON
Jill Tinmouth  Sunnybrook Research Institute
Toronto, ON 
Jennifer Brunet (Scientific Officer)  University of Ottawa
Ottawa, ON 
Stephen Ng (Community Representative) Canadian Cancer Society - British Columbia/Yukon Division
Vancouver, BC
Ryan Normore (Community Representative)  Canadian Cancer Society - Nova Scotia Division
Bedford, NS

Last modified on: October 29, 2014